Lexicon Pharmaceuticals
LXRX
#6206
Rank
ยฃ0.76 B
Marketcap
ยฃ1.72
Share price
-0.43%
Change (1 day)
91.88%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of March 2026 : ยฃ43.3 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is ยฃ43.3 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ46.64 M-46%
2024-12-31ยฃ86.37 M3.75%
2023-12-31ยฃ83.25 M82.15%
2022-12-31ยฃ45.7 M2607.08%
2021-12-31ยฃ1.68 M-82.03%
2020-12-31ยฃ9.39 M-94.99%
2019-12-31ยฃ0.18 B-2.91%
2018-12-31ยฃ0.19 B6.18%
2017-12-31ยฃ0.18 B121.09%
2016-12-31ยฃ82.21 M18.36%
2015-12-31ยฃ69.46 M0.44%
2014-12-31ยฃ69.15 M421.42%
2013-12-31ยฃ13.26 M-8.59%
2012-12-31ยฃ14.5 M-9.41%
2011-12-31ยฃ16.01 M-13.2%
2010-12-31ยฃ18.45 M-55.41%
2009-12-31ยฃ41.38 M98.9%
2008-12-31ยฃ20.8 M31.74%
2007-12-31ยฃ15.79 M-3.9%
2006-12-31ยฃ16.43 M-23.29%
2005-12-31ยฃ21.42 M9.28%
2004-12-31ยฃ19.6 M-37.77%
2003-12-31ยฃ31.49 M1162.6%
2002-12-31ยฃ2.49 M
2000-12-31ยฃ1.9 M-35.51%
1999-12-31ยฃ2.95 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ32.38 B 74,693.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ1.90 B 4,308.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ2.03 B 4,589.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
ยฃ27.01 M-37.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.33 B 683.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.18 B 337.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.25 B 483.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.08 B 2,394.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ0.29 M-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA